Ovid Application Error
A prospective phase II randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia. Kennedy, Glen A. 1,2; Morris, Kirk L. 1; Subramonpillai, Elango 1; Curley, Cameron 1; Butler, Jason 1; Durrant, Simon 1 [Article] British Journal of Haematology. 161(6):794-801, June 2013.
(Format: HTML, PDF)